Clinical Trials Sponsored by Predicted, Reported and Observed Outcomes Foundation
Total 1 results
-
Predicted, Reported and Observed Outcomes FoundationSPIRITT ResearchCompletedSpinal StenosisUnited States
Sponsors and Collaborators
- Victor Montori
- Cardresearch
- CRMBM-CEMEREM
- Elim Pediatric Pharmaceuticals Inc.
- Rui-hua Xu, MD, PhD
- San MediTech(Huzhou)Co.,Ltd.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Caritas Freetown
- University Medical Center Goettingen
- Diego Hernan Giunta, MD
- Alberta Children's Hospital, Calgary, Canada
- Norsk Proteinintolerance, Norway
- ProteoSys AG
- Fondren Orthopedic Group L.L.P.
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Celtaxsys Aus Pty Limited
- AMTC & Associates
- Donders Institute for Brain, Cognition and Behavior
- Societa Italiana di Endoscopia Digestiva
- The Fifth Affiliated Hospital of Zunyi Medical College
- View Full List
Medical Conditions
- Auditory Hallucination, Verbal
- Orbital Tumor
- Malignant Ascites Due to Epithelial Carcinoma
- Postcomatose Unawareness State
- Plasmodium Falciparum Malaria (Drug Resistant)
- Atrial Fibrillation, Postoperative
- Prostate Cancer Recurrent
- Disturbance of Activity and Attention
- Non-compressible Torso Hemorrhage
- Non-dystrophic Myotonias
- Stereotactic Radioablation for Ventricular Tachycardia
- Spermatogenesis Arrest
- Normal Diameter of Optic Nerve
- Tube Disorders Eustachian
- Lymphedema of Arm
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Gynecologic Cancer
- Tularaemia
- Fibromyalgia Syndrome, Primary
- Fever, Sweats, and Hot Flashes
- View Full List
Drug Interventions
- Mupirocin Calcium
- Enzalutamide, Abiraterone
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Cytarabine ARA-C
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Atezolizumab
- Lamivudine
- Polyethylene glycol 3350
- Insulin
- Epimedium Prenylflavonoids Extract
- Ruxolitinib
- PF-00868554
- Cetrorelix 78 mg + 78 mg
- SERETIDE Diskus
- Oxycodone, fentanyl
- Indoximod
- Topotecan
- Flibanserin 100 mg dose every evening
- Bortezomib/dexamethasone
- Methotrexate
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belgium
- Contract Research Organizations in Chile
- Contract Research Organizations in Finland
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Italy
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Liberia
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Venezuela
- CRO list by country